Beata Schlichtholz
About
In The Last Decade
Beata Schlichtholz
18 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 88
- Oncology 767
- Molecular Biology 549
- Cancer Research 338
- Biotechnology 280
- Immunology 235
Countries citing papers authored by Beata Schlichtholz
This map shows the geographic impact of Beata Schlichtholz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beata Schlichtholz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beata Schlichtholz more than expected).
Fields of papers citing papers by Beata Schlichtholz
This network shows the impact of papers produced by Beata Schlichtholz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beata Schlichtholz. The network helps show where Beata Schlichtholz may publish in the future.
Co-authorship network of co-authors of Beata Schlichtholz
This figure shows the co-authorship network connecting the top 25 collaborators of Beata Schlichtholz. A scholar is included among the top collaborators of Beata Schlichtholz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beata Schlichtholz. Beata Schlichtholz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 9 | |
| 3 | 24 | |
| 4 | 18 | |
| 5 | 10 | |
| 6 | 15 | |
| 7 | 85 | |
| 8 | 11 | |
| 9 | 13 | |
| 10 | 70 | |
| 11 | 11 | |
| 12 | 36 | |
| 13 | Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment. | 63 |
| 14 | p53 antibodies in patients with various types of cancer: assay, identification, and characterization. | 117 |
| 15 | 128 | |
| 16 | 312 | |
| 17 | Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface. | 153 |
| 18 | The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. | 239 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.